Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you inject your Mounjaro dose and notice some liquid remaining in the pen afterwards, you have not made an error and your dose is not necessarily incomplete. The KwikPen is designed with a small volume of excess fluid built in; how the pen actually works explains why this happens more clearly than the packaging does. Each pen holds four weekly doses, and the filling tolerance the manufacturer sets means a visible residue after the plunger stops is entirely expected. That said, when something looks unusual, it is worth understanding the engineering rather than guessing — and if you have genuine doubts about whether your dose was delivered, your prescriber is the right person to ask. Mounjaro (tirzepatide) is a prescription-only medicine; every treatment decision, including what to do if an injection goes differently from planned, sits with the clinician overseeing your care, supported by the Patient Information Leaflet that came in the box.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is a multi-dose, single-patient device pre-filled at the factory to deliver four identical weekly injections. Eli Lilly fills each pen to a volume that accounts for the dead space inside the cartridge, the needle hub and the mechanical tolerances of the plunger mechanism. When the last dose is delivered and the plunger reaches its designed stop, a small quantity of solution (typically visible through the inspection window) remains in the barrel. This residual fluid in the pen is not spare medicine you missed; it is the engineering buffer that guarantees each of the four calibrated doses was delivered in full.
The Mounjaro Summary of Product Characteristics, published on the electronic Medicines Compendium, confirms that patients should not attempt to extract or use any liquid remaining after the four doses are complete. The same principle applies mid-pen: if the plunger stops at the marked position for your dose number, the correct volume has been injected, regardless of what the window shows. A fuller overview of tirzepatide covers how the dual GIP and GLP-1 receptor mechanism works once the medicine is absorbed subcutaneously, the delivery accuracy at the pen level is a prerequisite for that pharmacology to play out as the trial data predict.
SURMOUNT-1, which ran for 72 weeks across 2,539 adults and is published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% at the 15 mg maintenance dose. That level of consistency across thousands of injections depends entirely on dosing precision, which the pen design is built to protect.
Most of the time, liquid left in a Mounjaro pen is completely unremarkable. There are, however, a handful of situations where the residue might reflect a genuinely incomplete injection rather than normal fill tolerance. The NHS medicines guidance for tirzepatide outlines these: if the needle was not held in the skin for the recommended duration after the click (the SmPC advises keeping it in place for ten seconds), some of the dose can leak back along the needle track. A bent or blocked needle (which is why changing the needle for every injection matters) can also obstruct delivery.
Signs that suggest the dose may not have been delivered fully include: the pen did not produce a clear audible click at the start of injection; the window did not change from one dose marker to the next; the injection site showed an unusual amount of liquid on the skin surface afterwards; or the pen felt different to use compared with previous weeks. If you are wondering why there is some Mounjaro left in the pen, that question is worth exploring alongside this page if any of those signs apply to you, as is more detail on what liquid left in a Mounjaro pen can indicate.
Changing the needle before every injection reduces the risk of blockage significantly. Compatible replacement needles are available if you are running low. Alcohol swabs for cleaning the injection site are a separate but related step, small habits that protect each dose.
Do not inject again. That is the consistent advice from the SmPC and the NHS, and it applies even if you are confident the dose failed. Taking a double volume of tirzepatide in one week substantially increases the risk of side effects, nausea and vomiting are the most common, but more serious gastrointestinal effects are possible. The right action is to record what happened, note the date and dose number on the pen, and contact your prescriber or pharmacist to explain what you observed.
If you are managing your treatment through an online pharmacy, your aftercare team should be reachable the same day. At nume, clinical support is available seven days a week, contact the team if something about an injection looks or feels wrong. For questions about your titration schedule or what a missed or uncertain dose means for your next injection date, the general FAQs cover common scenarios, though specific clinical decisions always rest with your prescriber.
One practical note: if your pen is running low around a holiday or a Monday when a new delivery might be delayed, it is worth ordering your next pen a few days earlier than usual. How to order Mounjaro through a regulated UK pharmacy includes what to check before placing a repeat order. Running out unexpectedly is more disruptive to your treatment plan than ordering slightly ahead of schedule.
Once all four doses are used (and a small amount of residue remains, as expected) the pen should be disposed of safely. Used Mounjaro pens contain a needle and are classified as sharps waste; they must not go into household recycling or general rubbish. Most pharmacies, including GP surgeries, accept used sharps for disposal. A one-litre sharps container is a practical option if you prefer to collect pens at home between pharmacy visits. The NHS tirzepatide medicines page and the Mounjaro SmPC on the eMC both provide additional guidance on storage, handling and disposal that is worth keeping to hand throughout your treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.